Lease of bact/alert virtuo blood culture system with reagents and maintenance service
Ended Purchase Order Awarded Last action
- Contract number
- HT941025PE065
- Awardee
-
Medpharm Inc. UEI DLM6VHZ3VUN3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $123,323
Award facts
- Opportunity
-
- Lease of BacT/Alert Virtuo Blood Culture System Includes Reagents and Maintenance Service Solicitation · HT941025Q2066 · Posted Jun 13, 2025
- Contract value 17% obligated
-
- $123,322.60 Current, with exercised options
- $715,153.40 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Agana Heights, Guam
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $123,323 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $715,153.40 firm fixed price purchase order to Medpharm, Inc. (doing business as Procara) on October 1, 2025, for a five-year lease of a BacT/Alert Virtuo Blood Culture System with reagents and comprehensive maintenance services. The contract, which originated from solicitation HT941025Q2066 posted in June 2025, was awarded through full and open competition with no set-aside designation. Performance will take place at U.S. Naval Hospital Guam Laboratory in Agana Heights, Guam, with an ultimate completion date of September 30, 2030. The contract includes a base year from October 15, 2025, through October 14, 2026, followed by four one-year option periods.
Procara, a minority-owned, small disadvantaged business and Asian-Pacific American-owned enterprise based in Guam, is well-positioned to fulfill this requirement given its established history of supplying critical medical laboratory equipment and services to Department of Defense facilities throughout the Pacific region. The scope of work encompasses equipment leasing, consumable supplies including aerobic, anaerobic, and pediatric blood culture bottles, and full maintenance services with 24/7 technical support and emergency response capabilities of 2-4 hours. The procurement supports operational readiness of the Naval Hospital Guam Laboratory, enabling critical diagnostic capabilities for patient care at this key military medical facility.
Quick answers
Who was awarded contract HT941025PE065?
HT941025PE065 was awarded to Medpharm Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT941025PE065 worth?
The government has obligated $123,323 on HT941025PE065. Its potential value, with all options, is $715,153.
Was contract HT941025PE065 competed?
The extent of competition for HT941025PE065 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award